中宠股份(002891) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was CNY 560,025,402.84, representing a 41.58% increase compared to the same period last year[5]. - Net profit attributable to shareholders was CNY 21,129,830.61, up by 10.73% year-on-year[5]. - Basic earnings per share were CNY 0.0719, reflecting a 10.71% increase from the previous year[5]. - The total operating revenue for the current period reached ¥792,893,440.85, a significant increase of 41.4% compared to ¥560,025,402.84 in the previous period[25]. - Net profit attributable to the parent company was ¥23,397,267.22, representing an increase of 10.7% from ¥21,129,830.61 in the previous period[27]. - The company’s basic and diluted earnings per share improved to ¥0.0796, up from ¥0.0719 in the previous period[29]. Cash Flow - The net cash flow from operating activities was negative at CNY -20,607,568.48, a decrease of 204.69% compared to the previous year[5]. - The company reported a net cash inflow from operating activities of ¥751,754,705.13, compared to ¥523,425,021.64 in the prior period, indicating a growth of 43.5%[30]. - The net cash flow from operating activities was -62,788,556.39, compared to -20,607,568.48 in the previous period, indicating a decline[32]. - The total cash outflow from operating activities was 814,543,261.52, compared to 544,032,590.12 in the previous period[32]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,015,181,615.47, an increase of 2.70% from the end of the previous year[5]. - The total assets of the company amounted to approximately ¥3,096,606,202.33, an increase from ¥3,015,181,615.47 at the beginning of the year[19]. - Current assets totaled ¥1,382,333,698.75, compared to ¥1,337,168,993.09 at the start of the year, reflecting a growth of about 3.4%[19]. - Total liabilities stood at ¥1,739,458,917.37, up from ¥1,737,161,422.42, showing a slight increase[21]. - The total liabilities rose to ¥1,122,914,903.19, compared to ¥1,069,380,292.64 in the previous period, indicating a growth of 5%[29]. Equity - The total equity attributable to shareholders increased by 1.44% to CNY 1,818,877,375.13[5]. - The total equity attributable to shareholders reached ¥1,845,054,764.12, an increase from ¥1,818,877,375.13, showing a growth of 1.4%[29]. Expenses - The company’s financial expenses increased by 119.41% to CNY 627.66 due to higher interest expenses[8]. - The total operating costs amounted to ¥748,642,638.23, up 43.9% from ¥519,876,118.72 in the prior period, with operating costs specifically rising from ¥437,464,995.80 to ¥646,531,239.84[25]. - Research and development expenses increased to ¥11,768,512.49, up from ¥9,503,858.98, reflecting a commitment to innovation[27]. Cash and Cash Equivalents - Cash and cash equivalents decreased to ¥325,570,848.32 from ¥350,856,030.32, a decline of approximately 7.2%[19]. - The cash and cash equivalents at the end of the period were 313,310,788.36, compared to 299,030,321.43 at the end of the previous period[32]. - The company’s initial cash and cash equivalents balance was 349,994,838.32, compared to 280,465,542.86 in the previous period[32]. Government Subsidies - The company received government subsidies amounting to CNY 657,429.19 during the reporting period[7]. Other Financial Activities - The company reported a significant decrease in cash received from investment activities, down by 72.54% to CNY 9,149.00[11]. - The total cash inflow from investment activities was 91,993,257.39, down from 334,516,021.72 in the previous period[32]. - The net cash flow from investment activities was -13,300,038.55, a significant decrease from 97,412,887.09 in the previous period[32]. - Cash inflow from financing activities totaled 175,232,021.77, compared to 84,379,318.59 in the previous period, showing an increase[32]. - The net cash flow from financing activities was 38,367,532.69, a recovery from -58,673,733.06 in the previous period[32].